Raphamin for treating acute bronchitis in adults
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a medicine called Raphamin can safely and effectively treat acute bronchitis (a chest infection with cough) in adults. Raphamin may help reduce cough and breathing problems in the early stages of this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–64 years old
- Diagnosed with acute bronchitis within the last 3 days, with a productive cough and at least one other symptom like wheezing, chest discomfort, shortness of breath, or fever
- No history of chronic lung diseases like COPD, asthma, or emphysema
- No suspected pneumonia or bacterial infection requiring antibiotics
- No serious heart, kidney, liver, or immune system conditions
- Not pregnant, breastfeeding, or have given birth in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests AG2001, a new treatment for acute bronchitis. It aims to see if it reduces cough and sputum better than a placebo, helping you recover faster.
This trial tests a new medicine called Raphamin for treating sudden sinus infection (acute rhinosinusitis) in adults. It compares the medicine to a placebo to see if it can reduce symptoms like facial pain and pressure when started within the first 2 days of illness.
This trial tests if Raphamin can safely treat common cold symptoms in children. It is for kids who have had cold symptoms for less than 24 hours and have a fever of at least 100°F with other symptoms like stuffy nose or sore throat.
This study looks at how safe and helpful raxibacumab is for people who are sick with inhalational anthrax after being exposed in a large incident. It includes all ages and also includes pregnant and breastfeeding people, focusing on outcomes from standard emergency clinical care.
This study tests a new medicine for people with non-cystic fibrosis bronchiectasis. It aims to see if the drug can help reduce symptoms and improve quality of life.
This trial tests if a new cough syrup (Rengalin) helps children ages 6 months to 3 years with a dry cough from a viral cold. It aims to reduce cough severity and improve comfort for your child.
Hear when a new Bronchitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.